Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapy.

Background Enzyme replacement therapy (ERT) for infantile-onset Pompe disease has been commercially available for almost 10 years. We report the experience of its use in a cohort treated at three specialist lysosomal treatment centres in the UK.